Skip to main content
. 2022 Jul 20;29:426–461. doi: 10.1016/j.omtn.2022.07.018

Figure 2.

Figure 2

A schematic overview of the studies assessing m6A modification and A-to-I editing in CVDs to date

Colored numbers denote specific original publication reference. The black-colored reference71 forwards interested readers to a recent review specifically discussing the role epitranscriptomic modifications in brain physiology and diseases, which is out of topic of the present review.